# Lenox Hill Hospital – FDA Inspection, Apr 1, 2024

Source: https://www.keypedia.com/records/fda_inspections/lenox-hill-hospital/598b60cb-8ef2-4eaa-9354-161f2a8cb94b
Source feed: FDA_Inspections

> FDA inspection 1234686 of Lenox Hill Hospital, April 01, 2024. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 606. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1234686
- Company Name: Lenox Hill Hospital
- Inspection Date: 2024-04-01
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1315412 - 2026-04-29
- FDA Inspection 1116043 - 2019-12-13
- FDA Inspection 1037745 - 2017-12-14
- [FDA Inspection 952370 - 2015-10-30](https://www.keypedia.com/records/fda_inspections/lenox-hill-hospital/f34adf67-e341-46a3-8d1a-d912869865e8)
- [FDA Inspection 852371 - 2013-10-30](https://www.keypedia.com/records/fda_inspections/lenox-hill-hospital/09cb9301-8115-4fdf-bd7f-998cbcc9fc02)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/irina-gaberman/c863b2de-4c64-40d2-a390-289d293e5a8f)

Company: https://www.keypedia.com/companies/lenox-hill-hospital/18441af6-502b-46b8-9c33-7708b98f315c

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d